Portfolio

HLEND seeks to build a diversified portfolio of senior secured private credit investments in resilient, market-leading, upper-middle market companies that operate primarily in non-cyclical sectors.

Data as of May 31, 2026

$24.5B

Investments at Fair Value

9.3%

Portfolio Yield at Fair Value1

94%

Private Investments2

95%

First Lien Exposure3

99%

Floating Rate4

$251M

Weighted Average EBITDA5

Portfolio Companies89

Clear Filters
Company Name
Industry
Investment Type
Reference Rate & Spread11
Par Amount (thousands)
Amortized Cost (thousands)
Fair Value (thousands)
% of Total Portfolio
LOCI Bidco Limited (Law Business Research) Media 1st Lien Senior Secured Debt S + 5.25% $ 8,667 8,513 8,667 0.04%
Indicor LLC (Indicor) Machinery 1st Lien Senior Secured Debt S + 2.50% $ 20,293 19,975 20,362 0.08%
LSF12 Donnelly Bidco, LLC (Carlisle Fluid) Machinery 1st Lien Senior Secured Debt S + 6.50% $ 19,429 19,159 19,429 0.08%
Lsf12 Helix Parent LLC (Hillenbrand) Machinery 1st Lien Senior Secured Debt S + 3.50% $ 19,152 18,641 19,066 0.08%
Madison Safety & Flow LLC (Madison Safety & Flow) Machinery 1st Lien Senior Secured Debt S + 2.50% $ 3,215 3,209 3,228 0.01%
Radwell Parent, LLC Machinery 1st Lien Senior Secured Debt S + 4.75% $ 163,599 148,178 150,328 0.61%
Rotation Buyer, LLC (Rotating Machinery Services Inc) Machinery 1st Lien Senior Secured Debt S + 4.75% $ 91,625 72,167 67,854 0.28%
TK Elevator US Newco Inc (TK Elevator) Machinery 1st Lien Senior Secured Debt S + 2.75% $ 14,881 14,765 15,023 0.06%
Time Manufacturing Company Machinery 1st Lien Senior Secured Debt E + 6.50% € 13,231 14,520 12,599 0.05%
Time Manufacturing Company Machinery 1st Lien Senior Secured Debt S + 6.50% $ 13,168 12,984 10,727 0.04%
Advarra Holdings, Inc. (Advarra, Inc.) Life Sciences Tools & Services 1st Lien Senior Secured Debt S + 4.50% $ 214,551 207,057 208,531 0.85%
Bamboo US BidCo LLC (Simtra BioPharma Solutions) Life Sciences Tools & Services 1st Lien Senior Secured Debt E + 5.25% € 62,336 64,763 69,786 0.28%
Bamboo US BidCo LLC (Simtra BioPharma Solutions) Life Sciences Tools & Services 1st Lien Senior Secured Debt S + 5.25% $ 124,634 108,638 106,147 0.43%
Cambrex Corporation Life Sciences Tools & Services 1st Lien Senior Secured Debt S + 4.75% $ 44,491 39,765 39,254 0.16%
PerkinElmer U.S. LLC (PerkinElmer) Life Sciences Tools & Services 1st Lien Senior Secured Debt S + 4.50% $ 275,142 271,951 273,008 1.11%
Phantom Purchaser Inc (Pharmacord LLC) Life Sciences Tools & Services 1st Lien Senior Secured Debt S + 4.75% $ 115,837 99,322 98,934 0.40%
WCG Intermediate Corp (WCG) Life Sciences Tools & Services 1st Lien Senior Secured Debt S + 2.75% $ 7,609 7,609 7,559 0.03%
ULTRA III, LLC (Unitranche Holdings III, LLC) Investments in Joint Ventures Joint Ventures $ 750,000 418,291 412,685 1.68%
Aurelia Netherlands Midco 2 B.V. (Adevinta ASA) Interactive Media & Services 1st Lien Senior Secured Debt E + 4.75% € 125,373 137,909 144,586 0.59%
Cadillac Bidco S.À R.L. (Adevinta Spain SL) Interactive Media & Services 1st Lien Senior Secured Debt E + 4.75% € 43,415 51,057 49,783 0.20%
Acrisure LLC Insurance 1st Lien Senior Secured Debt S + 3.00% $ 18,582 18,575 17,688 0.07%
Acrisure LLC Insurance 1st Lien Senior Secured Debt S + 3.25% $ 2,589 2,583 2,461 0.01%
CRC Insurance Group LLC (Truist Insurance Holding) Insurance 1st Lien Senior Secured Debt S + 2.75% $ 10,049 10,013 9,977 0.04%
Summit Acquisition Inc. (K2 Insurance Services LLC) Insurance 1st Lien Senior Secured Debt S + 3.50% $ 17,369 17,302 17,456 0.07%
Trucordia Insurance Services LLC (Trucordia) Insurance 1st Lien Senior Secured Debt S + 3.25% $ 6,880 6,865 6,450 0.03%

Engage with HLEND

Start Here

Footnotes

  1. Computed as (a) the annual stated interest rate or yield plus the annual accretion of discounts and less any annual amortization of premiums, as applicable, on accruing (i) debt and (ii) other income producing securities, divided by (b) total accruing (i) debt and (ii) other income producing securities (at fair value). Actual yields earned over the life of each investment could differ materially from the yields presented above. Please refer to HLEND’s prospectus and filings, including Form 10-Q or Form 10-K for fair value disclosures.
  2. Private Investments represents level 3 investments in the investment portfolio where inputs to the valuation methodology are unobservable and significant to overall fair value measurement. Private investments includes investments in joint ventures.
  3. Based on the aggregate fair value of the investment portfolio as of May 31, 2026.
  4. Percentage based on aggregate fair value of performing debt and other income producing securities (excluding investments in joint ventures).
  5. Calculated with respect to all level 3 investments (or, with respect to weighted average loan to value, all level 3 debt investments) in the investment portfolio for which fair value is determined by the Investment Adviser (in its capacity as the investment adviser of HLEND, with assistance, at least quarterly, from a third-party valuation firm, and overseen by HLEND’s Board of Trustees), and excludes quoted assets and investments in joint ventures. In the case of weighted average EBITDA only, excludes investments with no reported EBITDA or where EBITDA, in the Investment Adviser’s judgement made in its discretion, was not a material component of the original investment thesis, such as loan-to-value-based loans, NAV-based loans or reorganized equity. Weighted average EBITDA is weighted based on the fair value of the total applicable level 3 investments. Loan to value is calculated as net debt through each respective investment tranche in which HLEND holds an investment divided by enterprise value or value of underlying collateral of the portfolio company. Weighted average loan to value is weighted based on the fair value of the total applicable level 3 debt investments. Excludes investments on non-accrual status as of October 31, 2024. Figures are derived from the most recent financial statements from portfolio companies.
  6. Includes “last out” portions of first lien senior secured loans.
  7. Secured debt at the holding company level.
  8. Based on MSCI / S&P Global Industry Classification Standard (“GICS”) industry definition. Totals may not sum due to rounding. 
  9. All figures are as of May 31, 2026 unless otherwise indicated. % of total portfolio shown above is measured as total fair value of investments.
  10. Other includes structured finance investments.
  11. Contractual rates on preferred equity investments may represent preference accruals that are not recognized through investment income of the fund and as such are not included in the calculation of yield. The fair value of these investments may be influenced by the stated preference accrual or a minimum return threshold.